String of investors re-up in €6m funding round for nanomedicine company Cristal

400

medical-07-27065-mVenture capital firms Thuja Capital, BioGeneration Ventures, Nedermaas have strengthened their backing of Dutch biopharmaceutical company Cristal Therapeutics by taking part in a €6m investment round.

Netherlands-based Chemelot Ventures invested in Cristal for the first time and joined as a shareholder.

Cristal said the financing will be used to launch the first clinical study of its cancer-fighting CriPec docetaxel.

Chemelot investment manager Marcel Kloosterman said, “Cristal Therapeutics’ technology is enabling a more effective use of existing medicines with fewer side effects for the patient and also demonstrates its social relevance.

“Additionally, Cristal Therapeutics is contributing to a substantial increase in high-grade biopharmaceutical knowledge in our Limburg region in the Netherlands. We look forward to the start of the first clinical study with great confidence.”

Copyright © 2014 AltAssets

Get the latest PE News & Research delivered to your inbox every morning